Open AccessCancer Pain: Part 2: Physical, Interventional and Complimentary Therapies; Management in the Community; Acute, Treatment‐Related and Complex Cancer Pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners
Author(s) -
Raphael Jon,
Hester Joan,
Ahmedzai Sam,
Barrie Janette,
FarqhuarSmith Paul,
Williams John,
Urch Catherine,
Bennett Michael I.,
Robb Karen,
Simpson Brian,
Pittler Max,
Wider Barbara,
EwerSmith Charlie,
DeCourcy James,
Young Ann,
Liossi Christina,
McCullough Renee,
Rajapakse Dilini,
Johnson Martin,
Duarte Rui,
Sparkes Elizabeth
Publication year - 2010
Publication title -
pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 97
eISSN - 1526-4637
pISSN - 1526-2375
DOI - 10.1111/j.1526-4637.2010.00841.x
Subject(s) - medicine , cancer pain , context (archaeology) , pain medicine , psychological intervention , cancer , physical therapy , analgesic , perspective (graphical) , palliative care , disease , intensive care medicine , health care , alternative medicine , psychiatry , nursing , paleontology , anesthesiology , biology , pathology , artificial intelligence , computer science , economics , economic growth
Objective. This discussion document about the management of cancer pain is written from the pain specialists' perspective in order to provoke thought and interest in a multimodal approach to the management of cancer pain, not just towards the end of life, but pain at diagnosis, as a consequence of cancer therapies, and in cancer survivors. It relates the science of pain to the clinical setting and explains the role of psychological, physical, interventional and complementary therapies in cancer pain. Methods. This document has been produced by a consensus group of relevant healthcare professionals in the United Kingdom and patients' representatives making reference to the current body of evidence relating to cancer pain. In the second of two parts, physical, invasive and complementary cancer pain therapies; treatment in the community; acute, treatment‐related and complex cancer pain are considered. Conclusions. It is recognized that the World Health Organization (WHO) analgesic ladder, whilst providing relief of cancer pain towards the end of life for many sufferers world‐wide, may have limitations in the context of longer survival and increasing disease complexity. To complement this, it is suggested that a more comprehensive model of managing cancer pain is needed that is mechanism‐based and multimodal, using combination therapies including interventions where appropriate, tailored to the needs of an individual, with the aim to optimize pain relief with minimization of adverse effects.